Plain-English translation of NCT06865417 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ulcerative Colitis research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a new medication called to see if it can help children and teenagers (ages 8–17) whose ulcerative colitis isn't controlled well by current treatments. Researchers want to learn whether this medication is safe, well tolerated, and effective at reducing inflammation and symptoms in young patients with moderate to severe disease.
Many children with ulcerative colitis don't respond well to existing treatments like corticosteroids or biologic therapies, or they can't tolerate them. This trial is exploring whether this medication, which works through a different mechanism, might offer relief for young patients who have run out of other options.
You likely qualify if…
You likely don't qualify if…
Over about 6 months, you'll take the medication daily at home in the morning. You'll visit the study site three times (at weeks 4, 10, and 22) to take the medication there and let researchers check how you're doing. Researchers will monitor how well the medication works, check for side effects, and measure how your body processes the drug through blood tests and colonoscopies.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Belgium
Croatia